Plus, the stocks to get you through.   Read More

Shares of the French drugmaker are getting pummeled over at least three analyst reports identifying a leak about a study or studies that could go public soon. Their research suggests the data is related to a suspected or "theoretical" higher cancer risk associated with SNY's Lantus.    Read More

On Tuesday afternoon stocks were trading near break-even as investors sifted through comments from President Obama on a wide range of issues from energy to health care.   Read More

Shares of Lilly are off about 6% over the past month – down much more than the overall healthcare sector. Why can’t Lilly get any love?   Read More

The judge threw the book at the man, but at the same time he didn't sentence him by the book. Andrew Bodnar pleaded guilty to his role in the generic Plavix brouhaha a couple of years ago. And yesterday a District Court judge fined him $5,000 and ordered Bodnar to write a book about what happened. Write a book!    Read More

For people struggling with diabetes, the bathroom scale can be the enemy. But new developments may change that and more!   Read More

Cramer makes the call on viewers' favorite stocks.   Read More

In less than two weeks, there've been four pretty significant events in biopharma. And, hopefully, after ADA things will begin to settle down a bit for the summer.    Read More

How will male General Motors retirees get their motor runnin'? Do they start paying for their impotence drugs out of their own pocket? Because apparently, under the new deal the company won't pick up the tab anymore.    Read More

Much is understandably being made of the fact that Judge Sonia Sotomayor would be the first Hispanic to sit on the United States Supreme Court, assuming she's confirmed. But in my space, there could be a certain degree of buzz over something else in her background.    Read More